Business GrowthMIR’s Nuclear & Safety business continues to have significant growth tailwinds that should be supportive of MIR’s targeted +6%-8% organic growth in the business with still meaningful margin expansion potential.
Market PositionFavorable demand drivers and MIR’s strong position within its end markets could be durable growth drivers.
Medical Business GrowthMIR Medical is well positioned to deliver on its longer-term goals of 7%-9% organic growth and continued improvement in margin that should help MIR attain its 30% company-wide adjusted EBITDA margin goal.
Software IntegrationHigher margin software and service at approximately 30% of MIR’s RTQA business is quickly rising as a percentage of sales, which should provide margin tailwind for MIR.